How much revenue does Arev Life Sciences Global make?

Arev Life Sciences Global reported 49,113 CAD in revenue for fiscal year 2022, down 80.7% from 254,996 CAD in fiscal year 2021.

What companies are similar to Arev Life Sciences Global?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Quick-Med Technologies, Inc. (QMDT), Viropro Inc. (VPRO), Scopus BioPharma Inc. (SCPS), Regenicin, Inc. (RGIN).

Arev Life Sciences Global Corp. (AREVF) Stock

About Arev Life Sciences Global Corp.

AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES-...

At a glance

Arev Life Sciences Global reported revenue of 49,113 CAD for fiscal year 2022, down 80.7% from fiscal year 2021, and net income of -1.44 million CAD.

Figures from company filings; latest fiscal year ended December 31, 2022.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.